XNU0356
Supplement Lumbar Vertebra to New Technology Group 6 with Synthetic Substitute, Mechanically Expandable (Paired), Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | N Bones |
| Operation | U Supplement |
| Body Part | 0 Lumbar Vertebra |
| Approach | 3 Percutaneous |
| Device | 5 Synthetic Substitute, Mechanically Expandable (Paired) |
| Qualifier | 6 New Technology Group 6 |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family describes adding reinforcing material to bone that is still structurally present but weakened, deficient, or at risk of failure, using a New Technology product recognized for performance beyond older bone graft substitutes. Rather than replacing a bone segment outright, the surgeon builds up or strengthens the existing bone in place, often around screws, cages, or at fracture and fusion sites where added support improves the odds of solid healing.
Patients who receive these procedures often have osteoporotic bone, prior failed hardware, or a spinal fusion site judged likely to fail without extra augmentation. The technology involved is usually a bioactive or engineered bone-void filler or coating designed to encourage faster, stronger bone formation than conventional grafting material, which is the basis for its separate New Technology tracking.
Anatomy & Axis Detail
Lumbar Vertebra
A lumbar vertebra bears substantial axial load and is often the site of degenerative collapse, fracture, or bone loss that leaves the vertebral body structurally deficient. Supplementing it involves adding material, such as an engineered bone-graft substitute or biologic augmentation product cleared under newer technology pathways, to reinforce the existing bone rather than replacing or fusing it outright. Because the lumbar spine supports much of the trunk's weight and sits near the cauda equina and exiting nerve roots, the added material must integrate with native bone to restore load-bearing capacity without compromising canal or foraminal space. This distinguishes the procedure from fusion, since the vertebra's own structure is preserved and reinforced rather than joined to an adjacent segment, and documentation should specify the augmenting material and the vertebral level involved.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Synthetic Substitute, Mechanically Expandable (Paired)
This synthetic substitute is a spinal implant, most often an interbody device, that expands mechanically once positioned and is placed as a matched pair rather than a single unit. The paired configuration and mechanical expansion mechanism distinguish it from single expandable cages or static, non-expanding synthetic substitutes used in similar fusion procedures. Expansion in place allows restoration of disc height and lordosis through a smaller initial insertion footprint.
Qualifier: New Technology Group 6
This value marks Group 6, the cohort of new technologies added for the 2019-2020 fiscal year. As with every group qualifier in this section, it is a bookkeeping label showing when a technology earned a distinct code rather than a clue to its function, which is conveyed through the accompanying device or substance value. It should not be read as interchangeable with Group 5 or Group 7.
Coding & Documentation
Coding from this family requires the operative note to specify the augmentation product used and confirm that native bone was left intact and reinforced rather than removed, since that distinction separates Supplement from Replacement. Documentation should also make clear the site being reinforced, particularly when the same operative session includes fusion or instrumentation at nearby levels.
The most frequent mistake is coding routine bone graft material under this family when it does not meet the New Technology product criteria; only the specifically approved technologies qualify, and generic autograft or allograft belongs elsewhere. Coders also sometimes miss that Supplement codes here are reported in addition to, not instead of, any fusion codes for the same operative encounter.
Commonly Confused With
It is most often confused with Replacement, and the deciding question is always whether the original bone was removed (Replacement) or kept and reinforced (Supplement). It can also be mistaken for standard bone grafting captured outside the New Technology section, which applies when the material used does not carry the specific technology designation this family requires.